4//SEC Filing
COVINO GREGORY F 4
Accession 0001062993-22-023385
CIK 0001799850other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 9:23 PM ET
Size
8.5 KB
Accession
0001062993-22-023385
Insider Transaction Report
Form 4
Renovacor, Inc.RCOR
COVINO GREGORY F
Director
Transactions
- Disposition to Issuer
Stock Option
2022-12-01−24,000→ 0 totalExp: 2031-09-03→ Common Stock (24,000 underlying) - Disposition to Issuer
Stock Option
2022-12-01−12,000→ 0 totalExp: 2032-05-25→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]Represents Company Options (as defined in the Agreement and Plan of Merger, dated as of September 19, 2022, by and among the Issuer, Rocket Pharmaceuticals, Inc. ("Rocket") and the other parties thereto (the "Merger Agreement")), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent.
- [F2]Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement.
Issuer
Renovacor, Inc.
CIK 0001799850
Entity typeother
Related Parties
1- filerCIK 0001224116
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 9:23 PM ET
- Size
- 8.5 KB